Recoverin Antibody [L5J18]

Katalog-Nr. F4055

Drucken

Biologische Beschreibung

Spezifität Recoverin Antibody [L5J18] detektiert endogene Spiegel des gesamten Recoverin-Proteins.
Hintergrund Recoverin (RCVRN) ist ein neuronales Kalziumsensorprotein (NCS), das vorwiegend in Photorezeptoren der Netzhautst belexponiert wird. Dort reguliert es die Phototransduktionskaskade durch Ca²⁺-abh gige Membranassoziation und Hemmung der Rhodopsinkinase (GRK1). Recoverin enth lt vier EF-Hand-Motive, aber nur EF2 und EF3 binden Ca²⁺ mit hoher Affinit t (K₁ ≈ 3–5 μM, K₂ ≈ 50–200 μM). Sein N-terminaler Gly2-Rest ist myristoyliert, was einen Ca²⁺-Myristoyl-Schaltermechanismus erm glicht. Im Dunkeln, wenn die intrazellul re [Ca²⁺]-Konzentration relativ hoch ist (~250–500 nM), wird die Myristoylgruppe im hydrophoben Kern des Proteins sequestriert (Apo- oder EF2-gebundene Zust de), wodurch Recoverin im Zytosol verbleibt. Bei doppelter Besetzung von Ca²⁺ an EF2 und EF3 extrudieren kooperative Konformations derungen die Myristoyleinheit, versteifen die Helix-C/D-Schleifen und legen eine hydrophobe Furche frei, die durch die konservierten Reste Tyr53, Phe23 und Trp31 gebildet wird. Diese Umlagerung erleichtert die Membranassoziation ber hydrophobe Insertion und erm glicht es Recoverin, die N-terminale amphipathische Helix (Reste 13–26) von GRK1 mit mikromolarer Affinit t zu binden, wodurch das aktive Zentrum der Kinase sterisch blockiert wird. Diese Hemmung verl ngert die aktive Lebensdauer von Rhodopsin, erweitert die ffnung cGMP-gesteuerter Kan le und beschleunigt die Photoantwort-Wiederherstellung, w hrend sie eine S ttigung der Photorezeptoren verhindert. Lichteinwirkung f hrt zu einem R ckgang von cGMP, zur Aktivierung von Guanylatcyclase-aktivierenden Proteinen und zu einer Reduktion von [Ca²⁺]ᵢ, was zur Dissoziation des Recoverin-GRK1-Komplexes und zur Inaktivierung von Rhodopsin f hrt. Eine St rung dieses Regulationsmechanismus durch Anti-Recoverin-Autoantik rper, wie sie bei der krebsassoziierten Retinopathie (CAR) beobachtet wird, verursacht apoptotischen Photorezeptorverlust und Nachtblindheit, w hrend Mutationen (z. B. E85Q), die die Ca²⁺-Empfindlichkeit ver ndern, mit Netzhautdegeneration in Verbindung gebracht werden.

Nutzungsinformationen

Anwendung WB, IHC Verdünnung
WB IHC
1:400 1:300
Reaktivität Mouse, Rat
Quelle Rabbit Monoclonal Antibody MW 23 kDa
Lagerpuffer PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
Lagerung
(Ab dem Datum des Erhalts)
-20°C (avoid freeze-thaw cycles), 2 years
WB
Experimental Protocol:
 
Sample preparation
1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature.
2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
5. Remove a small volume of lysate to determine the protein concentration;
6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
 
Electrophoretic separation
1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 10%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
 
Transfer membrane
1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
Recommended conditions for wet transfer: 200 mA, 60 min.
( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
 
Block
1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
2. Incubate the film in the blocking solution for 1 hour at room temperature;
3. Wash the film with TBST for 3 times, 5 minutes each time.
 
Antibody incubation
1. Use 5% skim milk powder to prepare the primary antibody working liquid , gently shake and incubate with the film at 4°C overnight;
2. Wash the film with TBST 3 times, 5 minutes each time;
3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
 
Antibody staining
1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.
IHC
Experimental Protocol:
 
Deparaffinization/Rehydration
1. Deparaffinize/hydrate sections:
2. Incubate sections in three washes of xylene for 5 min each.
3. Incubate sections in two washes of 100% ethanol for 10 min each.
4. Incubate sections in two washes of 95% ethanol for 10 min each.
5. Wash sections two times in dH2O for 5 min each.
6.Antigen retrieval: For Citrate: Heat slides in a microwave submersed in 1X citrate unmasking solution until boiling is initiated; continue with 10 min at a sub-boiling temperature (95°-98°C). Cool slides on bench top for 30 min.
 
Staining
1. Wash sections in dH2O three times for 5 min each.
2. Incubate sections in 3% hydrogen peroxide for 10 min.
3. Wash sections in dH2O two times for 5 min each.
4. Wash sections in wash buffer for 5 min.
5. Block each section with 100–400 µl of blocking solution for 1 hr at room temperature.
6. Remove blocking solution and add 100–400 µl primary antibody diluent in to each section. Incubate overnight at 4°C.
7. Remove antibody solution and wash sections with wash buffer three times for 5 min each.
8. Cover section with 1–3 drops HRPas needed. Incubate in a humidified chamber for 30 min at room temperature.
9. Wash sections three times with wash buffer for 5 min each.
10. Add DAB Chromogen Concentrate to DAB Diluent and mix well before use.
11. Apply 100–400 µl DAB to each section and monitor closely. 1–10 min generally provides an acceptable staining intensity.
12. Immerse slides in dH2O.
13. If desired, counterstain sections with hematoxylin.
14. Wash sections in dH2O two times for 5 min each.
15. Dehydrate sections: Incubate sections in 95% ethanol two times for 10 sec each; Repeat in 100% ethanol, incubating sections two times for 10 sec each; Repeat in xylene, incubating sections two times for 10 sec each.
16. Mount sections with coverslips and mounting medium.
 

Referenzen

  • https://pubmed.ncbi.nlm.nih.gov/26584024/
  • https://pubmed.ncbi.nlm.nih.gov/8242744/

Anwendungsdaten